ORTEXORTEX News
Tracking REPX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RE
Earnings PreviewREPX

REPX Bulls Hold Edge Ahead of Q2 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 6 Aug 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Riley Exploration Permian heads into today's Q2 report with analyst consensus firmly bullish but insider selling casting a quieter shadow over the setup.

The CEO-level selling is the most notable signal in the data. Bobby Riley — Founder, Chairman, and President — sold over $1 million of stock in June and made multiple smaller sales in May, accumulating roughly 53,000 net shares sold across the past 90 days for a combined value approaching $1.9 million. That pattern of consistent, rolling insider sales from the top is worth noting, even if individual transactions are modest relative to his 2.3% stake. The COO and Chief Accounting Officer also trimmed positions in July, adding weight to the directional read.

Options positioning offers a contrasting signal. Hedging demand looks unusually light heading into the print — the put/call ratio of 0.13 is actually running below its 20-day average of 0.14. That modest z-score of -0.26 reflects no particular rush for downside protection. Call-side interest dominates the options book, suggesting retail and institutional options players are not braced for a stumble. Peers broadly softened on Wednesday, with CHRD, CRGY, MGY, and SM each down 1-3%, while REPX itself fell 1.96% to $33. The stock has recovered just 1.5% over the past month, underperforming a peer group that is up 3-8% on the week.

The bull and bear cases ultimately hinge on execution. Bulls point to the conventional San Andres/Yeso model — lower decline rates, higher margins, lower breakeven — plus 10% guided production growth and an implied NAV of around $52 per share. The mean analyst target of $48.50 represents roughly 47% upside from current levels, and the most recent action from Roth Capital in late July was a straight reiterate of its Buy/$45 target. Bears focus on midstream ramp delays in New Mexico, commodity price sensitivity, and the company's leverage ratio — concerns that become harder to dismiss if oil prices stay soft. Short interest at 3.7% of float has risen about 5.5% over the past week but remains well within normal range; with borrow availability close to 1,900% of estimated short interest, there is no squeeze dynamic in play.

Today's report tests whether REPX can demonstrate the production growth and free cash flow conversion that justify its premium to peers — and whether the insider selling cadence reflects routine portfolio management or a more cautious read on near-term commodity margins.

Stocks in this article

See the live data behind this article on ORTEX.

Open REPX on ORTEX →

How this article was generated

Generated
6 Aug 2026, 04:48
Data as of
6 Aug 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.